Reine Allan

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Reine Allan
CIK #0001714023
EDGAR Form CIK 2011 - 2026
3 [0001714023]
4 [0001714023]
Form 3/4/5 Subject 2011 - 2026
Prime Medicine Inc
Reine Allan
Foghorn Therapeutics Inc
Palvella Therapeutics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2026-02-26 Grant 1,300,000 $0.00
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2025-08-01 Grant 850,000
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2025-08-01 Disposed to issuer 850,000
Prime Medicine Inc PRME
Common Stock
2025-05-21 Buy 125,000 $1.18 147,500
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2025-05-19 Grant 2,000,000 $0.00
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2025-05-08 Grant 75,000 $0.00
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2025-02-27 Grant 275,000 $0.00
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2024-12-05 Grant 75,000 $0.00
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2024-05-17 Grant 100,000 $0.00
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2024-01-17 Grant 600,000 $0.00
Foghorn Therapeutics Inc FHTX
Stock Option (right to buy) · derivative
2023-01-26 Grant 90,000 $0.00
Foghorn Therapeutics Inc FHTX
Stock Option (right to buy) · derivative
2022-01-26 Grant 135,000 $0.00
Foghorn Therapeutics Inc FHTX
Stock Options (Right to buy) · derivative
2021-08-09 Option exercise 26,892 $0.00
Foghorn Therapeutics Inc FHTX
Common Stock
2021-08-09 Option exercise 26,892 $3.72 100,038
Foghorn Therapeutics Inc FHTX
Stock Option (Right to Buy) · derivative
2021-01-28 Grant 120,000 $0.00
Palvella Therapeutics Inc PIRS
Stock Options (Right to Buy) · derivative
2019-02-26 Grant 162,500 $0.00
Palvella Therapeutics Inc PIRS
Stock Options (Right to buy) · derivative
2018-02-20 Grant 50,000 $0.00
Palvella Therapeutics Inc PIRS
Stock Options (Right to buy) · derivative
2018-02-20 Grant 53,833 $0.00
Palvella Therapeutics Inc PIRS
Common Stock
2017-08-17 Buy 20,000 $4.89 97,800
Palvella Therapeutics Inc PIRS
Common Stock
2017-08-16 Buy 45,000 $4.79 215,550
showing 20 of 21 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com